272 related articles for article (PubMed ID: 15482187)
1. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
Aoki Y; Tosato G
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
[TBL] [Abstract][Full Text] [Related]
2. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
[TBL] [Abstract][Full Text] [Related]
5. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
6. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis.
Gasperini P; Sakakibara S; Tosato G
J Leukoc Biol; 2008 Oct; 84(4):994-1000. PubMed ID: 18319288
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?
Schulz TF; Moore PS
Trends Microbiol; 1999 May; 7(5):196-200. PubMed ID: 10354594
[TBL] [Abstract][Full Text] [Related]
9. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
10. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
11. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma.
Codish S; Abu-Shakra M; Ariad S; Zirkin HJ; Yermiyahu T; Dupin N; Boshoff C; Sukenik S
Am J Hematol; 2000 Dec; 65(4):310-4. PubMed ID: 11074561
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
13. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma.
Klass CM; Offermann MK
Curr Opin Oncol; 2005 Sep; 17(5):447-55. PubMed ID: 16093794
[TBL] [Abstract][Full Text] [Related]
14. Potential heterosexual Kaposi's sarcoma-associated herpesvirus transmission in a couple with HIV-induced immunodepression and with Kaposi's sarcoma and multicentric Castleman's disease.
Tirelli U; Gaidano G; Errante D; Carbone A
AIDS; 1996 Sep; 10(11):1291-2. PubMed ID: 8883593
[No Abstract] [Full Text] [Related]
15. Kaposi's sarcoma and other manifestations of human herpesvirus 8.
Geraminejad P; Memar O; Aronson I; Rady PL; Hengge U; Tyring SK
J Am Acad Dermatol; 2002 Nov; 47(5):641-55; quiz 656-8. PubMed ID: 12399755
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies.
Viejo-Borbolla A; Ottinger M; Schulz TF
Curr HIV/AIDS Rep; 2004 Apr; 1(1):5-11. PubMed ID: 16091217
[TBL] [Abstract][Full Text] [Related]
18. Central pontine myelinolysis complicating treatment of multicentric Castleman's disease and Kaposi's sarcoma in a patient with AIDS.
Apoola A; Ross J; Duddy MJ; Mudaliar V; Jones EL; Huengsberg M; Miller RF
Sex Transm Infect; 2003 Jun; 79(3):179-84. PubMed ID: 12794197
[TBL] [Abstract][Full Text] [Related]
19. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Said J
West J Med; 1997 Jul; 167(1):37-8. PubMed ID: 9265864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
